M E Mendelsohn
Overview
Explore the profile of M E Mendelsohn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
2846
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Durante W, Schafer A, Hrbolich J, Claure R, Mendelsohn M, Kroll M
Platelets
. 2010 Nov;
4(3):135-40.
PMID: 21043858
The effect of endothelium-derived relaxing factor (EDRF) and related compounds on platelet aggregation in response to physiological and pathological levels of arterial wall shear stress (30-120 dyne/cm(2)) was investigated. Platelets...
2.
Mendelsohn M
Climacteric
. 2009 Oct;
12 Suppl 1:18-21.
PMID: 19811235
This brief review summarizes the current state of the field for estrogen receptor actions in the cardiovascular system and the cardiovascular effects of hormone replacement therapy (HRT). It is organized...
3.
Peter I, Kelley-Hedgepeth A, Huggins G, Housman D, Mendelsohn M, Vita J, et al.
J Hum Hypertens
. 2009 Feb;
23(10):636-44.
PMID: 19194457
Increased arterial stiffness and wave reflection have been identified as cardiovascular disease risk factors. In light of significant sex differences and the moderate heritability of vascular function measures, we hypothesized...
4.
5.
Nuedling S, Karas R, Mendelsohn M, Katzenellenbogen J, Katzenellenbogen B, Meyer R, et al.
FEBS Lett
. 2001 Oct;
502(3):103-8.
PMID: 11583108
Physiological effects of estrogen on myocardium are mediated by two intracellular estrogen receptors, ERalpha and ERbeta, that regulate transcription of target genes through binding to specific DNA target sequences. To...
6.
Karas R, SCHULTEN H, Pare G, Aronovitz M, Ohlsson C, Gustafsson J, et al.
Circ Res
. 2001 Sep;
89(6):534-9.
PMID: 11557741
The two known estrogen receptors, ERalpha and ERbeta, mediate the effects of estrogen in all target tissues, including blood vessels. We have shown previously that estrogen inhibits vascular injury response...
7.
Karas R, van Eickels M, Lydon J, Roddy S, Kwoun M, Aronovitz M, et al.
J Clin Invest
. 2001 Aug;
108(4):611-8.
PMID: 11518735
Clinical studies of hormone replacement therapy to prevent cardiovascular diseases have heightened interest in the cardiovascular effects of progestins. However, the role of the progesterone receptor (PR) in vascular biology...
8.
Mosca L, Collins P, Herrington D, Mendelsohn M, Pasternak R, Robertson R, et al.
Circulation
. 2001 Jul;
104(4):499-503.
PMID: 11468217
No abstract available.
9.
Yuhanna I, Zhu Y, Cox B, Hahner L, Osborne-Lawrence S, Lu P, et al.
Nat Med
. 2001 Jul;
7(7):853-7.
PMID: 11433352
Atherosclerosis is the primary cause of cardiovascular disease, and the risk for atherosclerosis is inversely proportional to circulating levels of high-density lipoprotein (HDL) cholesterol. However, the mechanisms by which HDL...
10.
Wyckoff M, Chambliss K, Mineo C, Yuhanna I, Mendelsohn M, Mumby S, et al.
J Biol Chem
. 2001 May;
276(29):27071-6.
PMID: 11369763
Estrogen causes rapid endothelial nitric oxide (NO) production because of the activation of plasma membrane-associated estrogen receptors (ER) coupled to endothelial NO synthase (eNOS). In the present study, we determined...